The role of p38 MAPK in the adult muscle stem cell fate and regeneration in ageing

p38 MAPK 在成体肌肉干细胞命运和衰老再生中的作用

基本信息

  • 批准号:
    BB/H019243/1
  • 负责人:
  • 金额:
    $ 67.91万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

In part due to advances in modern medicine, many of us are living longer, and a greater proportion of the population of the Western world is over 60 than ever before. However, there is reduced benefit to these extra years of life if they are overshadowed by poor health; we want to increase 'healthspan' not 'lifespan'. What determines healthy ageing? What does it mean to die 'of old age' rather than some disease? We do not understand these processes yet. One strong candidate for the maintenance and repair of the body is a specialized cell called the adult stem cell. These differ from the embryonic stem cells that are so often in the press. Whereas embryonic stem cells have the ability to differentiate into any lineage (and become any tissue), the adult stem cell is committed to repairing and regenerating the tissue in which it resides. It achieves this by i, activating in response to cues, such as injury ii, proliferating, providing a pool of cells that will repair the damage and iii, through one of these cell divisions, replacing itself for future use. In the elderly, the ability of adult stem cells to perform these functions in markedly reduced, leading to gradual tissue deterioration. A good exemplar of this is skeletal muscle. After the age of 50, skeletal muscle mass declines by ~10% per decade; muscle also becomes weaker and contains more fat. On the positive side, studies in animals have determined that the decline in muscle adult stem cell (called the 'satellite' cell) behavior in ageing is not due to defects within the cell itself but is rather because the cell does not receive the correct signals from its environment. The overall aim of this project is to examine the theory that a key signaling molecule, called p38 MAPK, has a key role in interpreting these signals from the environment and dictating the way in which satellite cells subsequently behave; it therefore acts as a 'gateway'. p38 regulates many of the important events in muscle satellite cell activation, ranging from stopping cells dividing to changing the genes that are activated and therefore the proteins that the cell can make. If p38 is activated too soon, adult stem cells will not have sufficient opportunity to form enough cells for repair and replacement. We will address the following specific questions: 1) Does increased p38 activity restrict the 'choices' of muscle satellite cells? What would happen if p38 activity were suppressed? We will answer this by generating mice that lack p38 in adult muscle stem cells (knockout mice). We expect that they may produce increased numbers of precursor cells. 2) What are the first stages by which p38 regulates gene expression? DNA does not exist as a naked strand but is rather wound around groups of proteins called histones (the whole unit is called chromatin). Histones can be modified by the addition of methyl groups; it is now believed that these modifications ultimately change the shape of chromatin, either making it compact and inaccessible to molecules that will encourage gene expression (transcription factors), or 'opening' the chromatin so that transcription factors can function. We will examine two fundamental histone modifications, which regulate each of these events. 3) What are the signals that control p38 activation? Some of these will come from outside the cell, and some from inside. We will increase or decrease the activity of candidate regulators and determine the consequences for p38 activity and satellite cell function. 4) Most important, what changes occur in p38 activity during ageing? What happens if we prevent p38 activation in muscle satellite cells from old animals? We will test this using the knockout mice made in point 1. We predict that the normal decrease in satellite cell activation and proliferation that occurs in old mice will be ameliorated in the p38 knockout mice. This may prevent part of the decline in muscle mass that occurs in ageing.
部分由于现代医学的进步,我们中的许多人活得更长了,西方世界60岁以上人口的比例比以往任何时候都要大。然而,如果健康状况不佳,这些额外寿命的好处就会减少;我们想要增加“健康寿命”,而不是“寿命”。是什么决定了健康老龄化?死于“年老”而不是某种疾病是什么意思?我们还不了解这些过程。维持和修复身体的一个强有力的候选者是一种被称为成体干细胞的特殊细胞。这些干细胞不同于媒体经常报道的胚胎干细胞。胚胎干细胞有能力分化成任何谱系(并成为任何组织),而成体干细胞则致力于修复和再生其所在的组织。它通过以下方式实现这一点:1,对损伤等提示进行激活;2,增殖,提供修复损伤的细胞池;3,通过其中一个细胞分裂,替换自己以备将来使用。在老年人中,成体干细胞执行这些功能的能力显著降低,导致组织逐渐恶化。骨骼肌就是一个很好的例子。50岁以后,骨骼肌质量每十年下降~10%;肌肉也会变弱,含有更多的脂肪。从积极的方面来看,动物研究已经确定,肌肉成体干细胞(称为“卫星”细胞)在衰老过程中行为的下降不是由于细胞本身的缺陷,而是因为细胞没有从环境中接收到正确的信号。该项目的总体目标是检验一种关键信号分子p38 MAPK的理论,该分子在解释来自环境的这些信号和决定卫星细胞随后的行为方式方面起着关键作用;因此,它起到了“门户”的作用。P38调节肌肉卫星细胞激活中的许多重要事件,从停止细胞分裂到改变被激活的基因,从而改变细胞可以产生的蛋白质。如果p38过早被激活,成体干细胞将没有足够的机会形成足够的细胞进行修复和替换。我们将解决以下具体问题:1)p38活性的增加是否限制了肌肉卫星细胞的“选择”?如果p38活性被抑制会发生什么?我们将通过产生在成年肌肉干细胞中缺乏p38的小鼠(敲除小鼠)来回答这个问题。我们预计它们可能会产生更多的前体细胞。2) p38调控基因表达的第一个阶段是什么?DNA不是一条裸露的链,而是缠绕在一组叫做组蛋白的蛋白质上(整个单位叫做染色质)。组蛋白可以通过添加甲基来修饰;现在人们相信,这些修饰最终改变了染色质的形状,要么使染色质变得致密,使促进基因表达的分子(转录因子)无法进入,要么“打开”染色质,使转录因子能够发挥作用。我们将研究两个基本的组蛋白修饰,它们调节这些事件。3)控制p38激活的信号是什么?其中一些来自细胞外,一些来自细胞内。我们将增加或减少候选调节因子的活性,并确定对p38活性和卫星细胞功能的影响。最重要的是,在衰老过程中p38的活动发生了什么变化?如果我们阻止老年动物肌肉卫星细胞中的p38激活会发生什么?我们将使用第1点的基因敲除小鼠进行测试。我们预测,在p38基因敲除小鼠中,老年小鼠中发生的卫星细胞激活和增殖的正常下降将得到改善。这可能会部分防止衰老过程中肌肉质量的下降。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer Pell其他文献

Jennifer Pell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer Pell', 18)}}的其他基金

The role of p38 MAPK in the adult muscle stem cell fate and regeneration in ageing
p38 MAPK 在成体肌肉干细胞命运和衰老再生中的作用
  • 批准号:
    BB/H019243/2
  • 财政年份:
    2013
  • 资助金额:
    $ 67.91万
  • 项目类别:
    Research Grant

相似国自然基金

基于芍药甘草汤探寻AGEs-RAGE-P38 MAPK通路在高糖诱导软骨损伤中作用机制的研究
  • 批准号:
    2025JJ90034
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
钙调蛋白激酶PNCK磷酸化p38/MAPK通路调控黏附因子VCAM-1表达诱导肿瘤-血管定植促进肝癌播散的机制研究
  • 批准号:
    QN25H160126
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于p38 MAPK信号通路调控雄激素合成探讨慢性运动疲劳损伤男性生殖功能的机制及补肝汤的防治作用
  • 批准号:
    JCZRLH202500414
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
GADD45b促进p38 MAPK通路参与精神分裂症相关认知障碍发病机理研究
  • 批准号:
    JCZRYB202501511
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
P2X7受体介导的p38 MAPK/NF-κB信号通路在三叉神经痛中的作用与机制研究
  • 批准号:
    JCZRYB202500240
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
TGF-β1/p38 MAPK轴异常活化影响睾丸 微环境导致慢性睾丸炎生精损伤的机制 研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
槲皮素调控p38 MAPK/NF-κB/NLRP3信号通路对牙周炎正畸大鼠牙周组织重塑的影响
  • 批准号:
    2025JJ80537
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于p38 MAPK信号通路探讨肥胖促进早发型哮喘Th2型激素抵抗的机制
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
HMGB1通过TLR/p38 MAPK促进成骨分化及 改变染色质可及性抑制破骨分化的机制 研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
青稞花色苷基于“肠-肝 ”轴靶向 p38 MAPK 信号通路缓解肝脏慢性低度炎症的作用及机 制
  • 批准号:
    Q24C200027
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

The role of MKP-1/MAPK in hepatocytes and macrophages in alcohol-associated liver disease pathogenesis
MKP-1/MAPK在肝细胞和巨噬细胞中在酒精相关性肝病发病机制中的作用
  • 批准号:
    10679716
  • 财政年份:
    2023
  • 资助金额:
    $ 67.91万
  • 项目类别:
MKP5 allostery in MAPK regulation and signaling in the heart
MKP5 变构在心脏 MAPK 调节和信号传导中的作用
  • 批准号:
    10552036
  • 财政年份:
    2022
  • 资助金额:
    $ 67.91万
  • 项目类别:
MKP5 allostery in MAPK regulation and signaling in the heart
MKP5 变构在心脏 MAPK 调节和信号传导中的作用
  • 批准号:
    10375784
  • 财政年份:
    2022
  • 资助金额:
    $ 67.91万
  • 项目类别:
p38 MAPK activation as a therapeutic target for Friedreich ataxia
p38 MAPK 激活作为 Friedreich 共济失调的治疗靶点
  • 批准号:
    10518067
  • 财政年份:
    2022
  • 资助金额:
    $ 67.91万
  • 项目类别:
p38 MAPK activation as a therapeutic target for Friedreich ataxia
p38 MAPK 激活作为 Friedreich 共济失调的治疗靶点
  • 批准号:
    10641939
  • 财政年份:
    2022
  • 资助金额:
    $ 67.91万
  • 项目类别:
Regulation of thrombin-induced p38 MAPK pro-inflammatory signaling by deubiquitinases
去泛素酶对凝血酶诱导的 p38 MAPK 促炎信号的调节
  • 批准号:
    10794926
  • 财政年份:
    2022
  • 资助金额:
    $ 67.91万
  • 项目类别:
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
靶向 p38/JNK MAPK 改善顺铂引起的神经系统不良后遗症
  • 批准号:
    10437925
  • 财政年份:
    2021
  • 资助金额:
    $ 67.91万
  • 项目类别:
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
靶向 p38/JNK MAPK 改善顺铂引起的神经系统不良后遗症
  • 批准号:
    10285939
  • 财政年份:
    2021
  • 资助金额:
    $ 67.91万
  • 项目类别:
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
靶向 p38/JNK MAPK 改善顺铂引起的神经系统不良后遗症
  • 批准号:
    10668361
  • 财政年份:
    2021
  • 资助金额:
    $ 67.91万
  • 项目类别:
p38gamma MAPK signaling promotes intestinal tumorigenesis
p38gamma MAPK 信号促进肠道肿瘤发生
  • 批准号:
    10192684
  • 财政年份:
    2020
  • 资助金额:
    $ 67.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了